Routine testosterone screening of US troops may require extensive follow-on care, study finds
BLUF – A study published in JAMA found that approximately 26% of active-duty male Army personnel—an estimated 100,691 soldiers—had testosterone levels below 300 ng/dL, raising concerns that the Pentagon’s new routine screening program could generate substantial follow-up testing, medical evaluations and costs despite low screening values not necessarily indicating a clinical disorder. For Navy Medicine, the findings highlight the importance of confirming abnormal results with repeat morning testing, assessing symptoms before diagnosing testosterone deficiency and carefully weighing the potential benefits and risks of long-term testosterone replacement therapy.